• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT C4000; ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT C4000; ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE Back to Search Results
Catalog Number 02P24-01
Medical Device Problem Code Low Test Results (2458)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/07/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
 
Event or Problem Description
The customer observed a falsely depressed total bilirubin on the architect c4000 processing module for one patient.The following results were provided: initial total bilirubin result <0.1 mg/dl, repeat result= 0.5 mg/dl.There was no impact to patient management reported.
 
Additional Manufacturer Narrative
The architect c4000, serial number (b)(6) and sample probe were inspected.The sample probe was replaced, which resolved the issue.Return testing was not completed as returns were not available.The instrument service history review revealed no additional tickets associated with discrepant/erratic patient results.There were no additional service or complaint issues on or around the date this complaint was initiated that may have contributed to this issue.A review of tracking and trending of the architect c4000 did not identify any trends associated with the complaint issue.A review of tracking and trending for the sample probe did not identify any trends.A review of the manufacturing documentation did not identify any issues associated with the complaint issue.Labeling was reviewed and found to be adequate.Based on the available information, no systemic issue or deficiency of the architect c4000 processing module for serial (b)(6) or the sample probe was identified.
 
Event or Problem Description
The customer observed a falsely depressed total bilirubin on the architect c4000 processing module for one patient.The following results were provided: initial total bilirubin result <0.1 mg/dl, repeat result= 0.5 mg/dl.There was no impact to patient management reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT C4000
Common Device Name
ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE
Manufacturer (Section D)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
Manufacturer (Section G)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key21191794
Report Number3016438761-2025-00043
Device Sequence Number14319608
Product Code JJE
UDI-Device Identifier00380740003746
UDI-Public(01)00380740003746
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/30/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number02P24-01
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 12/31/2024
Supplement Date Received by Manufacturer01/30/2025
Initial Report FDA Received Date01/20/2025
Supplement Report FDA Received Date01/30/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/01/2020
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARC TBILI2 KIT 900T, 04T09-20,; ARC TBILI2 KIT 900T, 04T09-20,; SAMPLE PROBE, 01G48-03, UNKNOWN
Patient SexUnknown
-
-